Skip to main content
. 2008 Nov 11;99(11):1946–1953. doi: 10.1038/sj.bjc.6604776

Table 2. Number of deaths observed (O) and expected (E), ratio of observed to expected deaths (O/E), and 95% CI for selected cancer sites, 1960–2003.

Cancer site (ICD-10 code) O O* E O*/E 95% CI*
Tongue, mouth, salivary gland and pharynx (C00–C14) 99 105.0 131.8 0.80 0.65–0.97
Oesophagus (C15) 125 132.6 120.1 1.10 0.92–1.31
Stomach (C16)a 588 623.7 542.2 1.15 1.06–1.25
Colon (C17–C18) 299 317.1 310.9 1.02 0.91–1.14
Rectum (C19–C21) 241 255.6 267.9 0.95 0.84–1.08
Liver (C22)a 154 163.3 129.3 1.26 1.07–1.48
Gallbladder (C23–C24)a 76 80.6 75.4 1.07 0.84–1.34
Pancreas (C25)a 223 236.5 225.2 1.05 0.92–1.20
Nose (C30–C31)a 8 8.5 8.0 1.06 0.46–2.09
Larynx (C32) 75 79.5 67.2 1.18 0.93–1.48
Bone (C40–C41) 13 13.8 21.4 0.64 0.34–1.10
Malignant melanoma (C43)a 33 35.0 48.0 0.73 0.50–1.02
Other skin (C44) 9 9.5 12.5 0.76 0.35–1.45
Connective tissue (C47 and C49)a 14 14.8 21.6 0.69 0.38–1.16
Prostate (C61)a 262 277.9 314.4 0.88 0.78–1.00
Testis (C62) 25 26.5 25.3 1.05 0.68–1.55
Kidney (C64–C66)a 162 171.8 161.6 1.06 0.91–1.24
Bladder (C67–C68)a 173 183.5 224.4 0.82 0.70–0.95
Brain and other nervous system (C70–C72)a 110 116.7 124.2 0.94 0.77–1.13
Thyroid gland (C73)a 18 19.1 13.9 1.38 0.81–2.17
Hodgkin's disease (C81)a 29 30.8 35.1 0.88 0.59–1.26
Non-Hodgkin's disease (C82–C85 and C91.4)a 85 90.2 91.6 0.98 0.79–1.22
Myeloma (C90)a 51 54.1 52.6 1.03 0.77–1.35
Leukaemia (C91–C95, except C91.4) 127 134.7 150.9 0.89 0.74–1.06
 Leukaemia excluding chronic lymphatic (C91–C95, except C91.1 and C91.4) 71 75.3 83.9 0.90 0.70–1.13
Other and unspecified 295 312.8 312.5 1.00 0.89–1.12
All cancers other than lung cancer (C00–C32 and C35–C97) 3340 3543.7 3488.2 1.02 0.98–1.05
a

Exclusion of some cases for specific years, as external rates are missing (in total 46 missing cases).

O*, corrected for missing causes of death, O*=O/0.943; E=expected cases based on age and calendar year standardised national mortality rates from Eastern Germany.